A major exchange-traded fund provider is going deep on two popular plays: megacap tech and weight loss drug stocks.
"It's going to be important to kind of keep an eye on this space," Mazza told CNBC's "ETF Edge" this week.
They are the Roundhill Daily 2X Long Magnificent Seven ETF (MAGX) and the Roundhill Daily Inverse Magnificent Seven ETF (MAGQ).
MAGX is designed to profit from "Magnificent Seven" gains, which comprises Alphabet , Amazon , Apple, Meta Platforms , Microsoft , Nvidia and Tesla .
"These are tools that can be used for traders who have short-term views on the Magnificent Seven — both positive and negative to express that view," said Mazza.
Persons:
Dave Mazza, Mazza, CNBC's, they're, They're
Organizations:
Investments, Apple, Microsoft, Nvidia, Tesla